Domestic Toric Intraocular Lens PA60ATT by Xi'an Eyedeal Receives Market Approval
Eyedea
Ophthalmic Medical Device R&D Developer
Johnson & Johnson
Medical Device R&D and Manufacturer
【Perspective · Ophthalmology Industry Navigation】
Major Events Monthly Report | Editor's Recommended Article
Winning Atlas· Centralized Procurement Scaling | Ophthalmic Optometry Column
Eyedeal Medical Technology Company Limited("Eyedea")TheHydrophobic Acrylic Toric Intraocular Lens PA60ATT Approved, becoming a new member of the domestically produced Toric IOL (Toric Intraocular Lens) group。
This product adoptsL-shaped haptic design, weak negative spherical aberration optics, cylindrical lens range 0.75D to 3.00D(Spherical Equivalent +0.5D to +36.0D), demonstrating "excellent rotational stability" and "precise astigmatism correction" in clinical data.
In the range of cylindrical diopters,The maximum cylindrical power of Eyedea PA60ATT is 3.00D., while imported products such as Alcon's AcrySof IQ Toric can reach up to 6.00D, and Johnson & Johnson's Tecnis Toric II can reach up to 4.50D. This difference raises a question worth exploring: in the intraocular lens market where "those who dominate the high-end segment dominate the world," is this toric design a rational choice by Eyedea based on clinical needs, or a phased strategy constrained by technical capabilities?
# The Clinical Logic Behind the 3.00D Upper Limit
The cylindrical lens range of Eyedea PA60ATT (0.75D-3.00D) shows a certain gap compared to imported products. Alcon's AcrySof IQ Toric covers 1.50D-6.00D, and Johnson & Johnson's Tecnis Toric II covers 1.00D-4.50D, both of which can meet the correction needs for higher astigmatism.
Structural Distribution of Clinical Needs
According to the "Expert Consensus on the Clinical Application of Toric Intraocular Lenses in China," about 30%-40% of cataract patients have corneal astigmatism, with approximately 15%-20% having astigmatism greater than 1.00D, and only less than 5% having high astigmatism greater than 3.00D.Eyedea's cylindrical lens range covers more than 80% of clinical needs, which is reasonable from a market perspective.。
Prudent Avoidance of Technical Risks
The higher the cylindrical power, the more stringent the requirements for rotational stability. For every 1-degree rotation of a Toric IOL, the astigmatism correction effect decreases by approximately 3.3%; if the rotation exceeds 30 degrees, the corrective effect will be completely lost. High cylindrical powers (>4.00D) demand extremely high postoperative axial precision; if rotation occurs, a second surgery is required for adjustment, and the risk-benefit ratio must be carefully evaluated. Eyedea's "conservative" design,It may be a protective strategy for the early clinical safety of domestically produced products.。
Reasonable Consideration of Market Positioning
Data from national procurement shows that although the proportion of high-end functional IOLs (bifocal, trifocal, Toric) is low (about 15%), their growth is rapid. The upper limit of cylinder power at 3.00D indicates that Eyedea is currently focusing on the mainstream astigmatism population, a strategy that helps...Focus resources on core markets in the early stage of product launch.. The细分 market of patients with high astigmatism is currently covered by imported brands, leaving room for Eyedea's future product line upgrades.
# From "Innovative Materials" to "Mainstream Materials"
Eyedea's technical route choice has experienced a return from "innovative materials" to "mainstream materials."
The "Highlight Moment" of Cross-linked Polyisobutylene
The core technology accumulation of Eyedea lies inCross-linked Polyisobutylene (XL-PIB) Intraocular Lens, a novel biomaterial with excellent biocompatibility and optical stability. In September 2024, the cross-linked polyisobutylene IOL was approved for marketing, becoming the world's first of its kind. This material has been selected for China’s National "Challenge Leaderboard" list for innovative tasks in biomedical materials, and Eyedea has also been approved to establish the Shaanxi Provincial Academician Workstation.
"The Pragmatic Choice" of Hydrophobic Acrylic
The PA60ATT approved this time, however, returns to the mainstream hydrophobic acrylic material.This "switch" may be based on the following considerations.：The hydrophobic acrylic material has a mature production process, a complete industrial chain, and significant cost control potential; Toric IOLs require materials with higher foldability and resilience, and the long-term clinical data for cross-linked polyisobutylene is still being accumulated; under the centralized procurement framework, cost competitiveness and product innovation must be balanced.
Strategic Balance of Technology Routes
Eyedea has not abandoned cross-linked polyisobutylene but has formed a "dual-track approach":XL-PIB material is used for differentiated high-end products, while hydrophobic acrylic is used for mainstream products with high sales volume.. This "high-low combination" is more common in Chinese-produced IOL enterprises——Haohai Biotech has built a multi-subsidiary layout, mastering the full range of materials including PMMA, hydrophilic, and hydrophobic types; Aiborn has focused on hydrophobic acrylic, building a product matrix through optical designs such as single-focus, bifocal, trifocal, and Toric. Eyedea's "dual-material" strategy allows it to maintain flexibility between innovation and market adaptability.
# The Unique Aspects of Lens Design
The design details of PA60ATT reflect Eyedea's specific understanding of clinical needs.
Rotational Stability of L-shaped Haptics
A systematic review and meta-analysis published in 2022 showed that there are differences in the rotational stability of Toric IOLs with different haptic designs: dual-loop and plate-haptic designs exhibit the best rotational stability, followed by the traditional loop design, with the plate design performing the worst.
L-shaped haptic belongs to the modified loop haptic., by increasing the contact area with the capsular bag to enhance friction, its rotational stability is between traditional haptics and dual-haptics. Clinical data from Eyedea shows "excellent" rotational stability at 1-12 months post-operation, but there is a lack of head-to-head comparative data with imported products.
Strategy for Depth of Field with Weak Negative Spherical Aberration
PA60ATT continues the weak negative spherical aberration design of Eyedea's single-focus enhanced product PA60AS1, aiming to increase intermediate distance depth of field. This strategy differentiates itself from Alcon’s "zero spherical aberration" and Johnson & Johnson’s "full aberration correction."
The advantage of weak negative spherical aberration lies in：Higher tolerance for corneal aberrations, suitable for patients with irregular corneas; improved intermediate vision (60-80cm), meeting daily reading needs. However, the trade-off is that distance vision may be slightly inferior to "zero spherical aberration" designs, and the risk of night glare requires long-term observation.
# Competition in the "Second Tier" of Chinese-Made Toric IOLs
Eyedea's entry has changed the competitive landscape of domestically produced Toric IOLs in China.
Eyedea's "First-Mover Advantage"
Aiborn Medical's **Prinmier® Toric IOL** was approved in 2016 as the first domestically produced Toric IOL in China, covering cylindrical lens powers from 1.00D to 4.50D, and has established a comprehensive clinical data system and physician training network. In the national procurement process, Aiborn is the only domestically produced company selected in the bifocal product category, with leading brand recognition.
Eyedea's "Misplacement Competition"
Eyedea has chosen to enter the market with a combination of "monofocal enhancement + astigmatism correction," rather than directly challenging Aibonuode's bifocal Toric. PA60ATT and PA60AS1 (monofocal enhancement) form a product matrix to meet the specific needs of "both correcting astigmatism and improving intermediate vision." This "segmented scenario" strategy helps to establish a differentiated advantage among populations with specific needs.
The "Full Range" Pressure of Haohai Biotech
Haohai Biotech boasts a full range of product lines, from PMMA to hydrophobic acrylic and from single-focus to multifocal lenses. Toric IOL is an essential part of its product portfolio. Facing the comprehensive layout of industry partners, Eyedea's key lies in finding its differentiated positioning. By leveraging a dual-material platform of "cross-linked polyisobutylene + hydrophobic acrylic" and a细分场景 strategy of "single-focus enhancement + astigmatism correction," it aims to build a unique advantage in the market.
# The Distance from "Approval" to "Scaling Up"
The approval of PA60ATT is just the first step in Eyedea's Toric IOL Long March.
Establishment of Clinical Trust
The clinical success of Toric IOL depends not only on the product itself but also on the accuracy of preoperative biometry, the precision of surgical axis marking, and the management of postoperative rotational stability. Eyedea needs to establish a complete"Product + Service" System, including compatibility with digital navigation systems, coverage of doctor training networks, and rapid response to adverse events.
The Game of National Access
The fourth batch of national procurement clearly covers the full range of intraocular lens products.. For Toric IOL,The centralized procurement channel has been opened.Eyedea needs to accelerate the accumulation of clinical cases and doctor reputation under the background of the normalization of centralized procurement, verify the safety and effectiveness of the product through real-world data, and make full preparations for future market access and expansion in centralized procurement.
Continuous Innovation in Materials
Cross-linked polyisobutylene is the technical feature of Eyedea. The long-term biocompatibility and optical stability data will determine whether Eyedea canPioneering a "New Material Blue Ocean" in the "Hydrophobic Acrylic Red Sea"The Toric IOL made of XL-PIB material may become an important differentiated competitive advantage for Eyedea to enter the high-end market in the future.
The 3.00D upper limit for cylindrical lenses may seem "conservative," but it actually represents a comprehensive balance of clinical needs, technical risks, and market strategy; the "return" to hydrophobic acrylic material may appear to be a "compromise," but in fact, it is a rational choice driven by cost competitiveness under the context of national procurement. The true differentiation of Eyedea does not lie in the parameters of a single product.But in the "cross-linked polyisobutylene + hydrophobic acrylic" dual-material platform, and the "monofocal enhancement + astigmatism correction" niche scenario positioning.
The competition of Toric IOL is a comprehensive performance comparison, including rotational stability, and what supports all of this isNot only the technical foundation of enterprises, but also their ability to maintain strategic composure in a changing market.。
Ophthalmology Solutions Case
